Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PTK-787/ZK-222584 expected to show improved selectivity as kinase inhibitor, according to SAR

June 29, 2000

Development of CI-1033, an irreversible inhibitor of EGF tyrosine kinase activity

June 29, 2000

Novel kininogen-derived antiangiogenic peptides emerge from joint research program

June 28, 2000

Apoptosis-inducing small molecule targeting Bcl-2 recently identified

June 28, 2000

Further details on pharmacological profile of FE-200486 presented at ENDO 2000

June 28, 2000

Two series of compounds inhibiting ribonucleotide reductase patented by Kyowa Hakko

June 27, 2000

BASF's new signal transduction inhibitors act on protein kinases

June 27, 2000

Novartis and Schering pursue novel therapeutic approach to angiogenic disorders

June 27, 2000

Schering AG to commence phase I clinical study with Oncolym

June 27, 2000

Promycin clinical studies put on hold

June 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...